Lumigenex (Suzhou) Co., Ltd. Is a fast-growing bio-technological company dedicated to the development of proprietary technologies that meet the ever-increasing demands on clinical diagnostic products. Based on our patented Time-Resolved Fluorescence Immunoassay (TRFIA) POCT platform, which is exclusively authorized by Kimberly-Clark, we are focused on developing cost-effective rapid diagnostic products in cardiology, women's health, infectious disease, oncology and metabolic diseases. Meanwhile, Lumigenex is also a strategic partner of domestic chest pain center.
